Form D · Pharmaceuticals

Zurex Pharma, Inc.

Middleton, WI · CIK 0001551289

Offering snapshot reported Dec 29, 2023 · SEC filing

Reported sold
$3.78M
Offering amount: $4M
Investors reported
14
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 14, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 29, 2023Initial$3,779,232No comparison14SEC filing
Jun 16, 2020Initial$7,495,040No comparison18SEC filing
Jun 11, 2018Initial$2,237,490No comparison11SEC filing
Aug 11, 2016Initial$6,236,068No comparison26SEC filing
Jul 1, 2014Initial$4,127,158No comparison13SEC filing
Jun 7, 2012Initial$6,200,000No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-501094

Source: Form D, filed Dec 29, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Connie Curran Director
Carmine J Durham Director, Executive
Alexander M Kasper Director, Executive
Gary J Lehman Director
Michael J. Liang Director
Andrew Morgan Executive
R Andrew Morgan Executive
Roy Andrew Morgan Executive
Frederick A. Robertson Director
Robert Truitt Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2113 Eagle Drive
Middleton, WI, 53562